The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development

LGW Kerkmeijer; Clifton D Fuller; Helena M Verkooijen; Marcel Verheij; Ananya Choudhury; Kevin J Harrington; Chris Schultz; Arjun Sahgal; Steven J Frank; Joel Goldwein; Kevin J Brown; Bruce D Minsky; Marco van Vulpen

doi:10.3389/fonc.2016.00215

The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development

LGW Kerkmeijer, Clifton D Fuller, Helena M Verkooijen, Marcel Verheij, Ananya Choudhury, Kevin J Harrington, Chris Schultz, Arjun Sahgal, Steven J Frank, Joel Goldwein, Kevin J Brown, Bruce D Minsky, Marco van Vulpen,

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

An international research consortium has been formed to facilitate evidence-based introduction of MR-guided radiotherapy (MR-linac) and to address how the MR-linac could be used to achieve an optimized radiation treatment approach to improve patients' survival, local, and regional tumor control and quality of life. The present paper describes the organizational structure of the clinical part of the MR-linac consortium. Furthermore, it elucidates why collaboration on this large project is necessary, and how a central data registry program will be implemented.

Original language	English
Article number	215
Journal	Frontiers in oncology
Volume	6
DOIs	https://doi.org/10.3389/fonc.2016.00215
Publication status	Published - 2016

Access to Document

10.3389/fonc.2016.00215

fonc-06-00215Final published version, 419 KB

Fingerprint

Dive into the research topics of 'The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development'. Together they form a unique fingerprint.

Cite this

Kerkmeijer, LGW., Fuller, C. D., Verkooijen, H. M., Verheij, M., Choudhury, A., Harrington, K. J., Schultz, C., Sahgal, A., Frank, S. J., Goldwein, J., Brown, K. J., Minsky, B. D., van Vulpen, M. (2016). The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development. Frontiers in oncology, 6, Article 215. https://doi.org/10.3389/fonc.2016.00215

@article{8669052177904df19c5201eab2296a3e,

title = "The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development",

abstract = "An international research consortium has been formed to facilitate evidence-based introduction of MR-guided radiotherapy (MR-linac) and to address how the MR-linac could be used to achieve an optimized radiation treatment approach to improve patients' survival, local, and regional tumor control and quality of life. The present paper describes the organizational structure of the clinical part of the MR-linac consortium. Furthermore, it elucidates why collaboration on this large project is necessary, and how a central data registry program will be implemented.",

author = "LGW Kerkmeijer and Fuller, {Clifton D} and Verkooijen, {Helena M} and Marcel Verheij and Ananya Choudhury and Harrington, {Kevin J} and Chris Schultz and Arjun Sahgal and Frank, {Steven J} and Joel Goldwein and Brown, {Kevin J} and Minsky, {Bruce D} and {van Vulpen}, Marco",

year = "2016",

doi = "10.3389/fonc.2016.00215",

language = "English",

volume = "6",

journal = "Frontiers in oncology",

issn = "2234-943X",

publisher = "Frontiers Media S. A.",

}

Kerkmeijer, LGW, Fuller, CD, Verkooijen, HM, Verheij, M, Choudhury, A, Harrington, KJ, Schultz, C, Sahgal, A, Frank, SJ, Goldwein, J, Brown, KJ, Minsky, BD, van Vulpen, M 2016, 'The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development', Frontiers in oncology, vol. 6, 215. https://doi.org/10.3389/fonc.2016.00215

The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development. / Kerkmeijer, LGW; Fuller, Clifton D; Verkooijen, Helena M et al.
In: Frontiers in oncology, Vol. 6, 215, 2016.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The MRI-Linear Accelerator Consortium

T2 - Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development

AU - Kerkmeijer, LGW

AU - Fuller, Clifton D

AU - Verkooijen, Helena M

AU - Verheij, Marcel

AU - Choudhury, Ananya

AU - Harrington, Kevin J

AU - Schultz, Chris

AU - Sahgal, Arjun

AU - Frank, Steven J

AU - Goldwein, Joel

AU - Brown, Kevin J

AU - Minsky, Bruce D

AU - van Vulpen, Marco

PY - 2016

Y1 - 2016

N2 - An international research consortium has been formed to facilitate evidence-based introduction of MR-guided radiotherapy (MR-linac) and to address how the MR-linac could be used to achieve an optimized radiation treatment approach to improve patients' survival, local, and regional tumor control and quality of life. The present paper describes the organizational structure of the clinical part of the MR-linac consortium. Furthermore, it elucidates why collaboration on this large project is necessary, and how a central data registry program will be implemented.

AB - An international research consortium has been formed to facilitate evidence-based introduction of MR-guided radiotherapy (MR-linac) and to address how the MR-linac could be used to achieve an optimized radiation treatment approach to improve patients' survival, local, and regional tumor control and quality of life. The present paper describes the organizational structure of the clinical part of the MR-linac consortium. Furthermore, it elucidates why collaboration on this large project is necessary, and how a central data registry program will be implemented.

U2 - 10.3389/fonc.2016.00215

DO - 10.3389/fonc.2016.00215

M3 - Article

C2 - 27790408

SN - 2234-943X

VL - 6

JO - Frontiers in oncology

JF - Frontiers in oncology

M1 - 215

ER -